LINC01972

Across TCGA pan-cancer cohorts, LINC01972 RNA differs between tumor and matched normal tissue in 9 of 18 cancer types tested, making tumor–normal expression one of LINC01972’s most consistent transcriptional readouts.

The strongest signal is observed in thyroid carcinoma (THCA), where LINC01972 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC01972 is over-expressed in tumor, although a few such as KICH and KIRP show the opposite, repressed pattern.

THCA, HNSC, and BRCA are the cancer types where LINC01972 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC01972 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
THCA	Male	II,III,IV	+0.172	.003	7	view →
HNSC	All	All	+0.053	.011	7	view →
BRCA	Female	All	+0.059	.002	6	view →
KICH	All	All	−0.194	<.001	4	view →
KIRP	All	All	−0.107	.009	4	view →
LUSC	All	All	+0.080	<.001	3	view →
KIRC	All	All	−0.070	.002	3	view →
UCEC	All	All	+0.085	.047	2	view →
STAD	All	All	+0.061	.018	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 9 strongest of 9 lineages.

LINC01972–THCA

Open the THCA breakdown →